{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:15:31Z","timestamp":1786979731285,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and hypothesis<\/jats:title>\n                    <jats:p>Evidence on OAB management remains suboptimal and methodological limitations in randomized control trials (RCTs) affect their comparability. High quality meta-analyses are lacking. This study aimed to compare selection and reporting of outcomes and outcome measures across RCTs as well as evaluate methodological quality and outcome reporting quality as a first stage in the process of developing core outcome sets (COS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      RCTs were searched using Pubmed, EMBASE, Medline, Cochrane, ICTRP and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">Clinicaltrials.gov<\/jats:ext-link>\n                      from inception to January 2020, in English language, on adult women. Pharmacological management, interventions, sample size, journal type and commercial funding were documented. Methodological and outcome reporting quality were evaluated using JADAD and MOMENT scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-eight trials (18,316 women) were included. Sixty-nine outcomes were reported, using 62 outcome measures. The most commonly reported outcome domains were efficacy (86.8%), safety (73.7%) and QoL (60.5%). The most commonly reported outcomes in each domain were urgency urinary incontinence episodes (UUI) (52.6%), antimuscarinic side effects (76.3%) and change in validated questionnaire scores (36.8%).<\/jats:p>\n                    <jats:p>\n                      A statistically significant correlation was found between JADAD and MOMENT (Spearman\u2019s rho\u2009=\u20090.548,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) scores. This indicates that higher methodological quality is associated with higher outcome reporting quality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Development of COS and core outcome measure sets will address variations and lead to higher quality evidence. We recommend the most commonly reported outcomes in each domain, as interim COS. For efficacy we recommend: UUI episodes, urgency and nocturia episodes; for safety: antimuscarinic adverse events, other adverse events and discontinuation rates; for QoL: OAB-q, PPBC and IIQ scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00192-021-05040-1","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T04:02:32Z","timestamp":1641787352000},"page":"1243-1250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcome reporting in randomized controlled trials (RCTs) on the pharmacological management of idiopathic overactive bladder (OAB) in women; a systematic review for the development of core outcome sets (COS)"],"prefix":"10.1007","volume":"33","author":[{"given":"Reem","family":"Moussa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Patricia","family":"Rada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Durnea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Betschart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Milhem","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Sedgwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0404-6335","authenticated-orcid":false,"given":"Stergios K.","family":"Doumouchtsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CHORUS: An International Collaboration for Harmonising Outcomes, Research and Standards in Urogynaecology and Women\u2019s Health (i-chorus.org)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"issue":"3","key":"5040_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.urology.2009.06.096","volume":"75","author":"M Ganz","year":"2010","unstructured":"Ganz M, Smalarz A, Krupski T, Anger J, Hu J, Wittrup-Jensen K, Pashos C. Economic costs of overactive bladder in the United States. Urology. 2010;75(3):526\u201332.","journal-title":"Urology"},{"issue":"10","key":"5040_CR2","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00192-019-04022-8","volume":"30","author":"F Hsu","year":"2019","unstructured":"Hsu F, Weeks C, Selph S, Blazina I, Holmes R, McDonagh M. Updating the evidence on drugs to treat overactive bladder: a systematic review. Int Urogynecol J. 2019;30(10):1603\u201317.","journal-title":"Int Urogynecol J"},{"key":"5040_CR3","doi-asserted-by":"crossref","unstructured":"Roxburgh C, Cook J, Dublin N. Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database System Rev. 2007.","DOI":"10.1002\/14651858.CD003190.pub3"},{"key":"5040_CR4","doi-asserted-by":"crossref","unstructured":"Page M, McKenzie J, Kirkham J, Dwan K, Kramer S, Green S, Forbes A. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions. Cochrane Database System Rev 2014.","DOI":"10.1002\/14651858.MR000035.pub2"},{"key":"5040_CR5","unstructured":"COMET Initiative | Home [Internet]. Comet-initiative.org. 2020 [cited 7 February 2020]. Available from: http:\/\/www.comet-initiative.org\/"},{"issue":"11","key":"5040_CR6","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","volume":"14","author":"J Kirkham","year":"2017","unstructured":"Kirkham J, Davis K, Altman D, Blazeby J, Clarke M, Tunis S, Williamson P. Core outcome set-STAndards for development: the COS-STAD recommendations. PLoS Med. 2017;14(11):e1002447.","journal-title":"PLoS Med"},{"issue":"12","key":"5040_CR7","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00192-018-3781-5","volume":"29","author":"C Durnea","year":"2018","unstructured":"Durnea C, Pergialiotis V, Duffy J, Bergstrom L, Elfituri A, Doumouchtsis S. A systematic review of outcome and outcome-measure reporting in randomised trials evaluating surgical interventions for anterior-compartment vaginal prolapse: a call to action to develop a core outcome set. Int Urogynecol J. 2018;29(12):1727\u201345.","journal-title":"Int Urogynecol J"},{"issue":"3","key":"5040_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ijgo.13079","volume":"148","author":"T Louren\u00e7o","year":"2019","unstructured":"Louren\u00e7o T, Pergialiotis V, Durnea C, Elfituri A, Haddad J, Betschart C, Falconi G, Nygaard C, Bergstrom L, Pattel M, Doumouchtsis S. A systematic review of reported outcomes and outcome measures in randomized trials evaluating surgical interventions for posterior vaginal prolapse to aid development of a core outcome set. Int J Gynecol Obstet. 2019;148(3):271\u201381.","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"5040_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/nau.24297","volume":"39","author":"M Rada","year":"2020","unstructured":"Rada M, Jones S, Falconi G, Milhem Haddad J, Betschart C, Pergialiotis V, Doumouchtsis S. A systematic review and meta-synthesis of qualitative studies on pelvic organ prolapse for the development of core outcome sets. Neurourol Urodynam. 2020;39(3):880\u20139.","journal-title":"Neurourol Urodynam"},{"issue":"1","key":"5040_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ijgo.12766","volume":"145","author":"LT de Mattos","year":"2019","unstructured":"de Mattos LT, Pergialiotis V, Durnea C, Elfituri A, Haddad J, Betschart C, et al. A systematic review of reported outcomes and outcome measures in randomized controlled trials on apical prolapse surgery. Int J Gynaecol Obstet. 2019;145(1):4\u201311.","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"5040_CR11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/1471-0528.15891","volume":"126","author":"S Doumouchtsis","year":"2019","unstructured":"Doumouchtsis S, Pookarnjanamorakot P, Durnea C, Zini M, Elfituri A, Haddad J, Falconi G, Betschart C, Pergialiotis V. A systematic review on outcome reporting in randomised controlled trials on surgical interventions for female stress urinary incontinence: a call to develop a core outcome set. BJOG: An Int J Obstetrics Gynaecol. 2019;126(12):1417\u201322.","journal-title":"BJOG: An Int J Obstetrics Gynaecol"},{"issue":"2","key":"5040_CR12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/nau.23871","volume":"38","author":"LT de Mattos","year":"2018","unstructured":"de Mattos LT, Pergialiotis V, Duffy J, Durnea C, Elfituri A, Haddad J, Betschart C, Falconi G, Doumouchtsis S. A systematic review on reporting outcomes and outcome measures in trials on synthetic mesh procedures for pelvic organ prolapse: urgent action is needed to improve quality of research. Neurourol Urodynam. 2018;38(2):509\u201324.","journal-title":"Neurourol Urodynam"},{"issue":"12","key":"5040_CR13","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1111\/1471-0528.15408","volume":"125","author":"V Pergialiotis","year":"2018","unstructured":"Pergialiotis V, Durnea C, Elfituri A, Duffy J, Doumouchtsis S. Do we need a core outcome set for childbirth perineal trauma research? A systematic review of outcome reporting in randomised trials evaluating the management of childbirth trauma. BJOG: An Int J Obstetrics Gynaecol. 2018;125(12):1522\u201331.","journal-title":"BJOG: An Int J Obstetrics Gynaecol"},{"issue":"4","key":"5040_CR14","first-page":"122","volume":"38","author":"M Rada","year":"2019","unstructured":"Rada M, Betschart C, Pergialiotis V, Haddad J, Falconi G, Doumouchtsis S. Analysis of primary and secondary outcome domains reported in randomised trials on surgery for female stress urinary incontinence. A systematic review. Pelviperineology. 2019;38(4):122\u20135.","journal-title":"Pelviperineology"},{"issue":"6","key":"5040_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ajog.2019.10.095","volume":"222","author":"V Pergialiotis","year":"2019","unstructured":"Pergialiotis V, Bellos I, Biliou E, Varnava P, Mitsopoulou D, Doumouchtsis S. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets. Am J Obstetrics Gynecol. 2019;222(6):542\u2013550.e6.","journal-title":"Am J Obstetrics Gynecol"},{"issue":"4","key":"5040_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/1471-0528.16412","volume":"128","author":"V Ghai","year":"2020","unstructured":"Ghai V, Subramanian V, Jan H, Pergialiotis V, Thakar R, Doumouchtsis S. A systematic review on reported outcomes and outcome measures in female idiopathic chronic pelvic pain for the development of a core outcome set. BJOG: An Int J Obstetrics Gynaecol. 2020;128(4):628\u201334.","journal-title":"BJOG: An Int J Obstetrics Gynaecol"},{"issue":"5","key":"5040_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00192-018-3753-9","volume":"30","author":"V Ghai","year":"2019","unstructured":"Ghai V, Pergialiotis V, Jan H, Duffy J, Doumouchtsis S. Obstetric anal sphincter injury: a systematic review of information available on the internet. Int Urogynecol J. 2019;30(5):713\u201323.","journal-title":"Int Urogynecol J"},{"issue":"37","key":"5040_CR18","doi-asserted-by":"publisher","first-page":"e16876","DOI":"10.1097\/MD.0000000000016876","volume":"98","author":"M Rada","year":"2019","unstructured":"Rada M, Pergialiotis V, Betschart C, Falconi G, Haddad J, Doumouchtsis S. A protocol for developing, disseminating and implementing a core outcome set for stress urinary incontinence. Medicine (Baltimore). 2019;98(37):e16876.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5040_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12884-020-03070-z","volume":"20","author":"S Doumouchtsis","year":"2020","unstructured":"Doumouchtsis S, Rada M, Pergialiotis V, Falconi G, Haddad J, Betschart C. A protocol for developing, disseminating and implementing a core outcome set (COS) for childbirth pelvic floor trauma research. BMC Pregnancy Childbirth. 2020;20(1):376.","journal-title":"BMC Pregnancy Childbirth"},{"key":"5040_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2020.01.049","volume":"247","author":"C Nygaard","year":"2020","unstructured":"Nygaard C, Tsiapakidou S, Pape J, Falconi G, Betschart C, Pergialiotis V, Doumouchtsis S. Appraisal of clinical practice guidelines on the management of obstetric perineal lacerations and care using the AGREE II instrument; CHORUS an international collaboration for Harmonising outcomes research; standards in health; Women\u2019s health. European J Obstetrics Gynaecol Reproduct Biol. 2020;247:66\u201372.","journal-title":"European J Obstetrics Gynaecol Reproduct Biol"},{"key":"5040_CR21","doi-asserted-by":"crossref","unstructured":"Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J, Clarke M, Devereaux P, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ [Internet]. 2009 [cited 30 January 2020];339:b2700. Available from: https:\/\/www.bmj.com\/content\/339\/bmj.b2700.long","DOI":"10.1136\/bmj.b2700"},{"issue":"1","key":"5040_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1745-6215-14-70","volume":"14","author":"N Harman","year":"2013","unstructured":"Harman N, Bruce I, Callery P, Tierney S, Sharif M, O\u2019Brien K, Williamson P. MOMENT \u2013 Management of Otitis Media with effusion in cleft palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. Trials. 2013;14(1):70.","journal-title":"Trials"},{"issue":"1","key":"5040_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"A Jadad","year":"1996","unstructured":"Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D, McQuay H. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials. 1996;17(1):1\u201312.","journal-title":"Controlled Clin Trials"},{"issue":"3","key":"5040_CR24","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000051263","volume":"12","author":"M Oremus","year":"2001","unstructured":"Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer\u2019s disease drug trials. Dementia Geriatric Cognitive Disorders. 2001;12(3):232\u20136.","journal-title":"Dementia Geriatric Cognitive Disorders"},{"issue":"2","key":"5040_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.ijir.3901270","volume":"17","author":"Y Kim","year":"2004","unstructured":"Kim Y, Seo J, Yoon H. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women. Int J Impotence Res. 2004;17(2):158\u201363.","journal-title":"Int J Impotence Res"},{"issue":"10","key":"5040_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.4088\/JCP.15f10377","volume":"76","author":"C Andrade","year":"2015","unstructured":"Andrade C. The primary outcome measure and its importance in clinical trials. J Clin Psychiat. 2015;76(10):1320\u20133.","journal-title":"J Clin Psychiat"},{"issue":"8","key":"5040_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/1471-0528.16157","volume":"127","author":"J Duffy","year":"2020","unstructured":"Duffy J, Hirsch M, Vercoe M, Abbott J, Barker C, Collura B, Drake R, Evers J, Hickey M, Horne A, Hull M, Kolekar S, Lensen S, Johnson N, Mahajan V, Mol B, Otter A, Puscasiu L, Rodriguez M, et al. A core outcome set for future endometriosis research: an international consensus development study. BJOG: An Int J Obstetrics Gynaecol. 2020;127(8):967\u201374.","journal-title":"BJOG: An Int J Obstetrics Gynaecol"},{"key":"5040_CR28","doi-asserted-by":"publisher","first-page":"f5970","DOI":"10.1136\/bmj.f5970","volume":"347","author":"P Sedgwick","year":"2013","unstructured":"Sedgwick P. What is a patient preference trial? BMJ. 2013;347:f5970.","journal-title":"BMJ"},{"issue":"4","key":"5040_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ajog.2015.12.039","volume":"214","author":"M Hirsch","year":"2016","unstructured":"Hirsch M, Duffy J, Kusznir J, Davis C, Plana M, Khan K. Variation in outcome reporting in endometriosis trials: a systematic review. Am J Obstetrics Gynecol. 2016;214(4):452\u201364.","journal-title":"Am J Obstetrics Gynecol"},{"key":"5040_CR30","unstructured":"ICHOM | Overactive Bladder Standard Set | Measuring Outcomes [Internet]. ICHOM \u2013 International Consortium for Health Outcomes Measurement. 2020 [cited 11 February 2020]. Available from: https:\/\/www.ichom.org\/portfolio\/overactive-bladder\/."}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-05040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-021-05040-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-021-05040-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T10:05:48Z","timestamp":1652954748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-021-05040-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["5040"],"URL":"https:\/\/doi.org\/10.1007\/s00192-021-05040-1","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Details of ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}